Jean Clairambault
Jean Clairambault
directeur de recherche, INRIA
Verified email at - Homepage
Cited by
Cited by
Circadian timing in cancer treatments
F Lévi, A Okyar, S Dulong, PF Innominato, J Clairambault
Annual review of pharmacology and toxicology 50, 377-421, 2010
Linear and non-linear analyses of heart rate variability: a minireview
P Mansier, J Clairambault, N Charlotte, C Médigue, C Vermeiren, ...
Cardiovascular research 31 (3), 371-379, 1996
Heart rate variability in normal sleeping full-term and preterm neonates
J Clairambault, L Curzi-Dascalova, F Kauffmann, C Médigue, C Leffler
Early Human Development 28 (2), 169-183, 1992
Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies
A Lorz, T Lorenzi, ME Hochberg, J Clairambault, B Perthame
ESAIM: Mathematical Modelling and Numerical Analysis-Modélisation …, 2013
Emergence of drug tolerance in cancer cell populations: an evolutionary outcome of selection, nongenetic instability, and stress-induced adaptation
RH Chisholm, T Lorenzi, A Lorz, AK Larsen, LN Almeida, A Escargueil, ...
Cancer research 75 (6), 930-939, 2015
Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors
A Lorz, T Lorenzi, J Clairambault, A Escargueil, B Perthame
Bulletin of mathematical biology 77, 1-22, 2015
Decreased heart rate variability in transgenic mice overexpressing atrial beta 1-adrenoceptors
P Mansier, C Medigue, N Charlotte, C Vermeiren, E Coraboeuf, ...
American Journal of Physiology-Heart and Circulatory Physiology 271 (4 …, 1996
Cell population heterogeneity and evolution towards drug resistance in cancer: biological and mathematical assessment, theoretical treatment optimisation
RH Chisholm, T Lorenzi, J Clairambault
Biochimica et Biophysica Acta (BBA)-General Subjects 1860 (11), 2627-2645, 2016
Heart-rate variability in low-risk prematurely born infants reaching normal term: a comparison with full-term newborns
M Eiselt, L Curzi-Dascalova, J Clairambault, F Kauffmann, C Medigue, ...
Early human development 32 (2-3), 183-195, 1993
Heart rate and heart rate variability during sleep in small-for-gestational age newborns
L Spassov, L Curzi-Dascalova, J Clairambault, F Kauffmann, M Eiselt, ...
Pediatric research 35 (4), 500-504, 1994
Enabling multiscale modeling in systems medicine
O Wolkenhauer, C Auffray, O Brass, J Clairambault, A Deutsch, D Drasdo, ...
Genome medicine 6, 1-3, 2014
The p53 protein and its molecular network: modelling a missing link between DNA damage and cell fate
J Eliaš, L Dimitrio, J Clairambault, R Natalini
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1844 (1), 232-247, 2014
Implications of circadian clocks for the rhythmic delivery of cancer therapeutics
F Lévi, A Altinok, J Clairambault, A Goldbeter
Philosophical Transactions of the Royal Society A: Mathematical, Physical …, 2008
An age-and-cyclin-structured cell population model for healthy and tumoral tissues
F Bekkal Brikci, J Clairambault, B Ribba, B Perthame
Journal of mathematical biology 57, 91-110, 2008
Applying ecological and evolutionary theory to cancer: a long and winding road
F Thomas, D Fisher, P Fort, JP Marie, S Daoust, B Roche, C Grunau, ...
Evolutionary Applications 6 (1), 1-10, 2013
A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery
A Ballesta, S Dulong, C Abbara, B Cohen, A Okyar, J Clairambault, F Levi
PLoS computational biology 7 (9), e1002143, 2011
Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy
C Pouchol, J Clairambault, A Lorz, E Trélat
Journal de Mathématiques Pures et Appliquées 116, 268-308, 2018
Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations
T Lorenzi, RH Chisholm, J Clairambault
Biology direct 11, 1-17, 2016
Stability analysis of systems with distributed delays and application to hematopoietic cell maturation dynamics
H Ozbay, C Bonnet, J Clairambault
2008 47th IEEE conference on decision and control, 2050-2055, 2008
Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma
M Rabé, S Dumont, A Álvarez-Arenas, H Janati, J Belmonte-Beitia, ...
Cell death & disease 11 (1), 19, 2020
The system can't perform the operation now. Try again later.
Articles 1–20